Hirofumi Misaka

654 total citations
9 papers, 544 citations indexed

About

Hirofumi Misaka is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Neurology. According to data from OpenAlex, Hirofumi Misaka has authored 9 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Radiology, Nuclear Medicine and Imaging, 4 papers in Molecular Biology and 2 papers in Neurology. Recurrent topics in Hirofumi Misaka's work include Monoclonal and Polyclonal Antibodies Research (5 papers), Glycosylation and Glycoproteins Research (3 papers) and Barrier Structure and Function Studies (2 papers). Hirofumi Misaka is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (5 papers), Glycosylation and Glycoproteins Research (3 papers) and Barrier Structure and Function Studies (2 papers). Hirofumi Misaka collaborates with scholars based in Japan and Singapore. Hirofumi Misaka's co-authors include Shigeru Iida, Kenya Shitara, Mitsuo Satoh, Keiichi Yano, Miho Inoue, Naoko Yamane‐Ohnuki, Masako Wakitani, Ryosuke Nakano, Katsuhiro Mori and Mami Shibata and has published in prestigious journals such as Clinical Cancer Research, Biochemical and Biophysical Research Communications and Biotechnology and Bioengineering.

In The Last Decade

Hirofumi Misaka

9 papers receiving 527 citations

Peers

Hirofumi Misaka
Sabine Münkel Germany
Sharon Yang United States
Stefania Martignone Italy
Rita Pellegrini Italy
Brian W. Raden United States
Christiane Samarut France
Matthias Kaup Germany
Simon Brack Switzerland
Judy S. Wang United States
Brigitte Collet France
Sabine Münkel Germany
Hirofumi Misaka
Citations per year, relative to Hirofumi Misaka Hirofumi Misaka (= 1×) peers Sabine Münkel

Countries citing papers authored by Hirofumi Misaka

Since Specialization
Citations

This map shows the geographic impact of Hirofumi Misaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirofumi Misaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirofumi Misaka more than expected).

Fields of papers citing papers by Hirofumi Misaka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hirofumi Misaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirofumi Misaka. The network helps show where Hirofumi Misaka may publish in the future.

Co-authorship network of co-authors of Hirofumi Misaka

This figure shows the co-authorship network connecting the top 25 collaborators of Hirofumi Misaka. A scholar is included among the top collaborators of Hirofumi Misaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hirofumi Misaka. Hirofumi Misaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Ikeda, Masahiro, Miki Yamaguchi, Kazunori Kato, et al.. (2015). Pr1E11, a novel anti-TROP-2 antibody isolated by adenovirus-based antibody screening, recognizes a unique epitope. Biochemical and Biophysical Research Communications. 458(4). 877–882. 17 indexed citations
2.
Ando, Hiroshi, Masayo Suzuki, Hirofumi Misaka, et al.. (2015). Generation of specific monoclonal antibodies against the extracellular loops of human claudin-3 by immunizing mice with target-expressing cells. Bioscience Biotechnology and Biochemistry. 79(8). 1272–1279. 5 indexed citations
3.
Suzuki, Masayo, Akiko Furuya, Yuzuru Abe, et al.. (2009). Therapeutic antitumor efficacy of monoclonal antibody against Claudin‐4 for pancreatic and ovarian cancers. Cancer Science. 100(9). 1623–1630. 69 indexed citations
4.
Iida, Shigeru, Reiko Kuni‐Kamochi, Katsuhiro Mori, et al.. (2009). Two mechanisms of the enhanced antibody-dependent cellular cytotoxicity (ADCC) efficacy of non-fucosylated therapeutic antibodies in human blood. BMC Cancer. 9(1). 58–58. 81 indexed citations
5.
Iida, Shigeru, Hirofumi Misaka, Katsuhiro Mori, et al.. (2009). Nonfucosylated rituximab potentiates human neutrophil phagocytosis through its high binding for FcγRIIIb and MHC class II expression on the phagocytotic neutrophils. Experimental Hematology. 37(3). 309–321. 93 indexed citations
6.
Iida, Shigeru, Hirofumi Misaka, Miho Inoue, et al.. (2006). Nonfucosylated Therapeutic IgG1 Antibody Can Evade the Inhibitory Effect of Serum Immunoglobulin G on Antibody-Dependent Cellular Cytotoxicity through its High Binding to FcγRIIIa. Clinical Cancer Research. 12(9). 2879–2887. 174 indexed citations
7.
Kanda, Yutaka, Naoko Yamane‐Ohnuki, Naoto Sakai, et al.. (2006). Comparison of cell lines for stable production of fucose‐negative antibodies with enhanced ADCC. Biotechnology and Bioengineering. 94(4). 680–688. 90 indexed citations
8.
Iida, Shinji, Hirofumi Misaka, & Masanao Naya. (1997). A flow cytometric analysis of cytotoxic effects of nitrobenzene on rat spermatogenesis.. The Journal of Toxicological Sciences. 22(5). 397–407. 13 indexed citations
9.
Takaba, Katsumi, Hirofumi Misaka, Tsuyoshi Takeda, et al.. (1997). A Simple Method for the Preparation of Cells from Rat Urinary Bladder Epithelium for Flow Cytometry.. Journal of Toxicologic Pathology. 10(4). 225–227. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sabine Münkel Breakdown of academic impact, for papers by Sharon Yang Breakdown of academic impact, for papers by Stefania Martignone Breakdown of academic impact, for papers by Rita Pellegrini Breakdown of academic impact, for papers by Brian W. Raden Breakdown of academic impact, for papers by Christiane Samarut Breakdown of academic impact, for papers by Matthias Kaup Breakdown of academic impact, for papers by Simon Brack Breakdown of academic impact, for papers by Judy S. Wang Breakdown of academic impact, for papers by Brigitte Collet
Rankless by CCL
2026